Stocks in Asia and US futures climbed ahead of crucial American jobs data that will help identify the path forward for Federal Reserve monetary tightening. Equities in Japan, Australia and South Korea rose. Shares in China and Hong Kong fluctuated after initially rallying on news reports Chinese officials would remove restrictions on property developer borrowing. Contracts for European futures and those for the S&P 500 advanced after the US index fell 1.2% on Thursday. Treasury 10-year yields retreated slightly after their first gain of the week on Thursday following comments from Fed officials. The dollar steadied and the yen fell to levels not seen in a week, after the Bank of Japan unveiled further unscheduled bond buying to control its yield curve. The broadly positive sentiment precedes US nonfarm payroll data to be released Friday. Estimates peg a decline in new jobs added, indicating a cooling in the labor market that would in turn reduce the need for higher interest rates. However, private payrolls data released Thursday surpassed estimates and a surprise fall in new claims for unemployment benefits underscored a robust jobs market. There are increasing signs of pressure on technology companies, with Samsung Electronics Co. the latest to report on a demand slump resulting in a 69% plunge in operating profit. Shares in the South Korean giant rose as speculation mounted the hit to earnings would prompt the company to reduce capital expenditure. The rise in European stock futures comes ahead of eurozone consumer price index data due later today. Consensus forecasts suggest inflation fell to 9.5% in December from a year earlier, down from 10.1% recorded in November. Oil rose further after a string of declines that wiped nearly 10% from the price of crude. The price of gold increased after retreating Thursday from a six-month high reached earlier in the week. US After Hours WWE +10.5% jumps as Vince McMahon plans his return, will push for strategic alternatives; AEHR +15.5% higher on earnings; USNA -1.1% lower on guidance
Nikkei +0,59% Hang Seng -0,33% CSI +0,29% Shanghai +0,03% Shenzen +0,13%
Eur$ 1,0519 CNH 6,8599 CNY 6,8538 JPY 134,09 GBP 1,1917 CHF 0,9369 RUB 72,0237 TRY 18,7704 WTI$ 74,22 +0,7% Gold 1,839 +8,6% BTC 16,795 ETH 1,247
S&P +0,32% Nasdaq +0,29% EuroStoxx +0,63% FTSE +0,24% Dax +0,58% SMI +0,45%
Macro :
- Citi Strategists Raise European Stocks, Cut US to Underweight
- Goldman’s Bell Expects 2023 To Be a Tough Year for Returns
- Goldman’s Bell Expects 2023 To Be a Tough Year for Returns
- German Regulator ‘Very Optimistic’ About Gas Supply This Winter
Keep an eye on :
Keep an eye on :
- BAYN GY : MS Sees Rotation From ‘Safe-Haven’ Pharma Back Into Growth
- BNTX US : UK Signs BioNTech Deal to Treat 10,000 With Custom Cancer Drugs
- BNP FP : BNP Paribas Launches Tap Issue of €75M Convertible Bonds
- DANSKE DC : Danske Bank Says US Sentencing Completed as Previously Announced
- DANSKE DC : Danske Bank Says US Sentencing Completed as Previously Announced
- EPIA SS : European Industrials' Lost Russia Sales Eye Capex Bulk-Up Offset
- MBG GY : Mercedes Tries to Outdo Tesla With Its Own EV Charging Network
- MUV2 GY : Munich Re, Swiss Re Increase Rates as Protection Costs Surge 50%
- REN PL : REN Signs EU150m Long-Term Financing Contract With the EIB
- ROG SW : Roche: FDA Grants Priority Review to Glofitamab for Lymphoma
- STAN LN : StanChart Faces Fresh Questions Over Future After Bid Report
- SW FP : Sodexo 1Q Revenue Beats Estimates
- STLA IM : Stellantis May Shut More Plants as Electrification Costs Bite
- SREN SW : Munich Re, Swiss Re Increase Rates as Protection Costs Surge 50%
- UCB BB : UCB Says FDA to Review BLA for Rozanolixizumab With Priority
- DG FP : Vinci Energies Buys Otera; No Terms